Antidiabetic effect of two different Ganoderma species tested in alloxan diabetic rats. Issue 17 (11th March 2020)

• Record Type: Journal Article
• Authors: Rašeta, Milena; Popović, Mira; Čapo, Ivan; Stilinović, Nebojša; Vukmirović, Saša; Milošević, Biljana; Karaman, Maja
• Is Part Of: RSC advances. Volume 10:Issue 17(2020)
• Page Start: 10382
• Page End: 10393
• Publication Date: 2020-03-11
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/c9ra10158f
• Languages: English
• ISSNs: 2046-2069

Abstract

Abstract : Antidiabetic potentials of G. pfeifferi and G. resinaceum were obtained in this study and found to be of even higher bioactivity than the previously reported and well known G. lucidum . Abstract : This study was designed to define total protein, phenol and flavonoid content as well as LC-MS/MS phenolic profile related to antioxidant and antidiabetic activity of ethanolic (EtOH) and water extracts of G. pfeifferi and G. resinaceum . G. resinaceum water extract possessed the highest ability to scavenge DPPH˙ and O2 ˙ −, while the EtOH extract of the same species showed better activity on NO˙ related to other extracts. The highest level of bioactive compounds was determined generally in EtOH extracts. Antidiabetic action was evaluated by the oral glucose tolerance test (OGTT) and histological examination of pancreas and liver in normoglycemic and alloxan-induced diabetic animals. Histological examination of pancreatic tissue demonstrated that G. pfeifferi extracts have protective effects. To conclude, analysed extracts could be considered as a promising candidate for further research with the aim to promote antidiabetic activity, which is for the first time reported for G. pfeifferi .